Champlain Investment Partners LLC Has $140.61 Million Stock Position in Ryan Specialty Holdings, Inc. (NYSE:RYAN)

Champlain Investment Partners LLC decreased its holdings in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 39.9% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 2,191,580 shares of the company's stock after selling 1,452,670 shares during the quarter. Champlain Investment Partners LLC owned about 0.84% of Ryan Specialty worth $140,612,000 as of its most recent filing with the SEC.

Several other large investors have also recently bought and sold shares of the business. Vanguard Group Inc. grew its position in shares of Ryan Specialty by 5.7% in the fourth quarter. Vanguard Group Inc. now owns 9,880,504 shares of the company's stock valued at $633,933,000 after purchasing an additional 529,631 shares during the last quarter. Bessemer Group Inc. boosted its position in shares of Ryan Specialty by 2.5% in the fourth quarter. Bessemer Group Inc. now owns 3,283,216 shares of the company's stock worth $210,651,000 after acquiring an additional 79,976 shares during the last quarter. Blair William & Co. IL raised its position in shares of Ryan Specialty by 0.6% in the 4th quarter. Blair William & Co. IL now owns 2,765,963 shares of the company's stock worth $177,464,000 after buying an additional 16,540 shares during the period. Principal Financial Group Inc. lifted its position in Ryan Specialty by 115.2% during the fourth quarter. Principal Financial Group Inc. now owns 1,833,209 shares of the company's stock valued at $117,619,000 after buying an additional 981,505 shares in the last quarter. Finally, Geode Capital Management LLC boosted its position in shares of Ryan Specialty by 2.7% in the fourth quarter. Geode Capital Management LLC now owns 1,799,130 shares of the company's stock worth $115,468,000 after buying an additional 46,960 shares during the period. Hedge funds and other institutional investors own 84.82% of the company's stock.

Ryan Specialty Price Performance

RYAN stock traded up $2.54 during midday trading on Tuesday, reaching $69.94. 363,715 shares of the company's stock traded hands, compared to its average volume of 943,809. The company has a 50-day simple moving average of $70.47 and a two-hundred day simple moving average of $68.99. The company has a quick ratio of 1.01, a current ratio of 1.01 and a debt-to-equity ratio of 2.40. The company has a market cap of $18.32 billion, a price-to-earnings ratio of 101.53, a PEG ratio of 1.19 and a beta of 0.66. Ryan Specialty Holdings, Inc. has a 1-year low of $48.48 and a 1-year high of $77.16.

Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings data on Thursday, February 20th. The company reported $0.45 EPS for the quarter, missing analysts' consensus estimates of $0.47 by ($0.02). The firm had revenue of $663.53 million during the quarter, compared to the consensus estimate of $658.80 million. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. On average, analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 earnings per share for the current year.

Ryan Specialty Increases Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Investors of record on Tuesday, March 4th were given a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.69%. This is an increase from Ryan Specialty's previous quarterly dividend of $0.11. The ex-dividend date of this dividend was Tuesday, March 4th. Ryan Specialty's dividend payout ratio (DPR) is currently 69.57%.

Analyst Upgrades and Downgrades

Several brokerages have recently weighed in on RYAN. Keefe, Bruyette & Woods lowered their target price on Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research note on Wednesday, April 9th. TD Cowen started coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They issued a "buy" rating and a $89.00 price target on the stock. UBS Group raised their price target on shares of Ryan Specialty from $82.00 to $84.00 and gave the company a "buy" rating in a research note on Wednesday, February 26th. Wells Fargo & Company cut their price objective on shares of Ryan Specialty from $69.00 to $66.00 and set an "equal weight" rating on the stock in a research note on Thursday, April 10th. Finally, Royal Bank of Canada lowered their price target on Ryan Specialty from $73.00 to $72.00 and set a "sector perform" rating on the stock in a research report on Friday, February 21st. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and seven have given a buy rating to the company. Based on data from MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $75.67.

Insider Buying and Selling at Ryan Specialty

In related news, EVP Brendan Martin Mulshine sold 30,000 shares of the firm's stock in a transaction on Friday, March 14th. The shares were sold at an average price of $69.30, for a total transaction of $2,079,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Nicholas Dominic Cortezi sold 10,485 shares of the company's stock in a transaction on Thursday, January 23rd. The stock was sold at an average price of $65.12, for a total transaction of $682,783.20. Following the completion of the transaction, the director now directly owns 11,109 shares of the company's stock, valued at approximately $723,418.08. The trade was a 48.56 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 106,894 shares of company stock valued at $7,107,220. Corporate insiders own 11.10% of the company's stock.

Ryan Specialty Profile

Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.